171 related articles for article (PubMed ID: 22775544)
1. Dipyridamole-induced eczematous drug eruption with positive patch test reaction.
Salava A; Alanko K; Hyry H
Contact Dermatitis; 2012 Aug; 67(2):103-4. PubMed ID: 22775544
[No Abstract] [Full Text] [Related]
2. The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions.
Hassoun-Kheir N; Bergman R; Weltfriend S
Int J Dermatol; 2016 Nov; 55(11):1219-1224. PubMed ID: 27368159
[TBL] [Abstract][Full Text] [Related]
3. Fixed drug eruption from ticlopidine, with positive lesional patch test.
García CM; Carmena R; García R; Berges P; Camacho E; Cotter MP; de la Hoz B
Contact Dermatitis; 2001 Jan; 44(1):40-1. PubMed ID: 11156015
[No Abstract] [Full Text] [Related]
4. Papuloerythroderma caused by aspirin.
Sugita K; Koga C; Yoshiki R; Izu K; Tokura Y
Arch Dermatol; 2006 Jun; 142(6):792-3. PubMed ID: 16785396
[No Abstract] [Full Text] [Related]
5. Widespread eczema from triflusal confirmed by patch testing.
Sánchez-Machín I; García Robaina JC; Torre Morin F
Contact Dermatitis; 2004 Apr; 50(4):257. PubMed ID: 15186390
[No Abstract] [Full Text] [Related]
6. Repeated patch testing in delayed hypersensitivity to beta-lactam antibiotics.
Romano A; Di Fonso M; Pietrantonio F; Pocobelli D; Giannarini L; Del Bono A; Fabrizi G; Venuti A
Contact Dermatitis; 1993 Mar; 28(3):190. PubMed ID: 8462302
[No Abstract] [Full Text] [Related]
7. Delayed hypersensitivity drug reactions diagnosed by patch testing.
Calkin JM; Maibach HI
Contact Dermatitis; 1993 Nov; 29(5):223-33. PubMed ID: 8112060
[TBL] [Abstract][Full Text] [Related]
8. Delayed-type hypersensitivity reaction to ethambutol and isoniazid.
Bakkum RS; Waard-Van Der Spek FB; Thio HB
Contact Dermatitis; 2002 Jun; 46(6):359. PubMed ID: 12190628
[No Abstract] [Full Text] [Related]
9. Delayed-type hypersensitivity to protamine as a complication of insulin therapy.
Raap U; Liekenbröcker T; Kapp A; Wedi B
Contact Dermatitis; 2005 Jul; 53(1):57-8. PubMed ID: 15982236
[No Abstract] [Full Text] [Related]
10. Delayed adverse reaction to sodium ioxaglic acid-meglumine.
Kanny G; Marie B; Hoen B; Trechot P; Moneret-Vautrin DA
Eur J Dermatol; 2001; 11(2):134-7. PubMed ID: 11275812
[TBL] [Abstract][Full Text] [Related]
11. Eczematous infiltrated plaques to subcutaneous heparin: a type IV allergic reaction.
Bircher AJ; Flückiger R; Buchner SA
Br J Dermatol; 1990 Oct; 123(4):507-14. PubMed ID: 2151304
[TBL] [Abstract][Full Text] [Related]
12. [Delayed intracutaneous test reaction in heparin intolerance].
Wurpts G; Merk HF
Hautarzt; 2007 May; 58(5):394-6. PubMed ID: 17450341
[No Abstract] [Full Text] [Related]
13. Delayed-type drug hypersensitivity caused by paracetamol in a 2-year-old boy, confirmed by a positive patch test reaction and oral provocation.
Gilissen L; Mertens S; Goossens A; Bullens D; Morren MA
Contact Dermatitis; 2018 May; 78(5):362-363. PubMed ID: 29611267
[No Abstract] [Full Text] [Related]
14. Maculopapular rash due to delayed-type hypersensitivity from bismuth salts.
Gratacós Gómez AR; Joyanes Romo JB; Meneses Sotomayor JV; González Jimenez OM; Palacios Cañas A; Gómez Torrijos E
Contact Dermatitis; 2022 Mar; 86(3):228-229. PubMed ID: 34791673
[No Abstract] [Full Text] [Related]
15. Delayed hypersensitivity to aminopenicillins.
Romano A
Clin Exp Allergy; 1998 Sep; 28 Suppl 4():29-32. PubMed ID: 9761027
[No Abstract] [Full Text] [Related]
16. Delayed hypersensitivity to enoxaparin.
Cabañas R; Caballero MT; López-Serrano MC; Díaz R; Contreras J; Barranco P; Moreno-Ancillo A
J Investig Allergol Clin Immunol; 1998; 8(6):383-4. PubMed ID: 10028487
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous delayed reaction to ranitidine.
Gonzalo-Garijo MA; Revenga-Arranz F; Rovira-Farré I
Allergy; 1996 Sep; 51(9):659-60. PubMed ID: 8899121
[No Abstract] [Full Text] [Related]
18. Near-fatal delayed hypersensitivity reaction to cloxacillin.
Moreno-Ancillo A; Domínguez-Noche C; Gil-Adrados AC; Cosmes PM
Contact Dermatitis; 2003 Jul; 49(1):44-5. PubMed ID: 14641124
[No Abstract] [Full Text] [Related]
19. Bullous Fixed Drug Eruption Caused by Etoricoxib Confirmed by Patch Testing.
Carneiro-Leão L; Rodrigues Cernadas J
J Allergy Clin Immunol Pract; 2019; 7(5):1629-1630. PubMed ID: 30777670
[No Abstract] [Full Text] [Related]
20. Clopidogrel-induced hypersensitivity syndrome associated with febrile pancytopenia.
Comert A; Akgun S; Civelek A; Kavala M; Sarigül S; Yildirim T; Arsan S
Int J Dermatol; 2005 Oct; 44(10):882-4. PubMed ID: 16207199
[No Abstract] [Full Text] [Related]
[Next] [New Search]
